THTX — Theratechnologies Income Statement
0.000.00%
HealthcareAdventurousSmall CapNeutral
- $90.19m
- $127.02m
- $80.06m
- 42
- 46
- 26
- 30
Annual income statement for Theratechnologies, fiscal year end - November 30th, USD millions except per share, conversion factor applied.
R2018 November 30th | 2019 November 30th | 2020 November 30th | 2021 November 30th | 2022 November 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 45.2 | 63.2 | 66.1 | 69.8 | 80.1 |
Cost of Revenue | |||||
Gross Profit | 31.8 | 37.1 | 38.2 | 46.6 | 53.8 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 48.8 | 71.7 | 84 | 95.1 | 120 |
Operating Profit | -3.56 | -8.51 | -18 | -25.2 | -39.6 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -5.97 | -12.5 | -22.7 | -31.7 | -46.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | -4.7 | -12.5 | -22.7 | -31.7 | -47.2 |
Net Income Before Extraordinary Items | |||||
Net Income | -4.7 | -12.5 | -22.7 | -31.7 | -47.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -4.7 | -12.5 | -22.7 | -31.7 | -47.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.063 | -0.162 | -0.302 | -0.344 | -0.498 |